Quinapril and Hydrochlorothiazide 20/12.5 (Cipla USA Inc.)
Welcome to the PulseAid listing for the Quinapril and Hydrochlorothiazide 20/12.5 drug offered from Cipla USA Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cipla USA Inc. |
| NON-PROPRIETARY NAME: | Quinapril and Hydrochlorothiazide 20/12.5 |
| SUBSTANCE NAME: | QUINAPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-07-20 |
| END MARKETING DATE: | 0000-00-00 |
Quinapril and Hydrochlorothiazide 20/12.5 HUMAN PRESCRIPTION DRUG Details:
| Item Description | Quinapril and Hydrochlorothiazide 20/12.5 from Cipla USA Inc. |
| LABELER NAME: | Cipla USA Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2016-07-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69097-829_4d5399c0-8a0b-4140-bade-1a338866b769 |
| PRODUCT NDC: | 69097-829 |
| APPLICATION NUMBER: | ANDA201356 |
Other QUINAPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
